John G. Singer 2/20/25 John G. Singer 2/20/25 Is HIV Prevention and Treatment "Gender-Affirming Care"? Read More John G. Singer 2/17/25 John G. Singer 2/17/25 The Massive Grapple Ahead for Pharma Read More John G. Singer 2/13/25 John G. Singer 2/13/25 How to Sell AI in the Kingdom of the Bored Read More John G. Singer 2/6/25 John G. Singer 2/6/25 Whatever Happened to Eisai’s “Dementia Ecosystem”? Read More John G. Singer 1/31/25 John G. Singer 1/31/25 Should Eli Lilly Acquire Walgreens? Should Novo Nordisk? Read More John G. Singer 1/29/25 John G. Singer 1/29/25 Houston, We Need a New Narrative Read More John G. Singer 1/25/25 John G. Singer 1/25/25 Amazon, LillyDirect and Big Market Innovation Read More John G. Singer 1/16/25 John G. Singer 1/16/25 The Keystone Advantage for Pharma Read More John G. Singer 12/29/24 John G. Singer 12/29/24 The S&P 493 Has Run Out of Ideas Read More John G. Singer 12/17/24 John G. Singer 12/17/24 How to Crack the Mad Riddle of Healthcare Read More John G. Singer 11/20/24 John G. Singer 11/20/24 Executive Leaders’ Wile E. Coyote Moment Read More John G. Singer 11/15/24 John G. Singer 11/15/24 Navigating Industry-Level Risk Read More John G. Singer 10/30/24 John G. Singer 10/30/24 Escaping McKinseyLand is Hard, Even for McKinsey Read More John G. Singer 10/10/24 John G. Singer 10/10/24 Missing From Starboard’s “Extensive Slide Deck” to Turn Around Pfizer Read More John G. Singer 9/25/24 John G. Singer 9/25/24 A Note on the “Perverse Rebate System” in Action this Week Read More John G. Singer 9/24/24 John G. Singer 9/24/24 The “Strategic Direction” Thing Read More John G. Singer 9/11/24 John G. Singer 9/11/24 A “Radical” Strategy Story for Nestlé Read More John G. Singer 9/6/24 John G. Singer 9/6/24 A Note on the Launch of “PfizerForAll” Read More John G. Singer 9/3/24 John G. Singer 9/3/24 When Big PBM Business Models Are “Dead Men Walking” Read More John G. Singer 8/22/24 John G. Singer 8/22/24 Can Big Pharma Save Big Food? Read More Older Posts
John G. Singer 2/20/25 John G. Singer 2/20/25 Is HIV Prevention and Treatment "Gender-Affirming Care"? Read More
John G. Singer 2/6/25 John G. Singer 2/6/25 Whatever Happened to Eisai’s “Dementia Ecosystem”? Read More
John G. Singer 1/31/25 John G. Singer 1/31/25 Should Eli Lilly Acquire Walgreens? Should Novo Nordisk? Read More
John G. Singer 1/25/25 John G. Singer 1/25/25 Amazon, LillyDirect and Big Market Innovation Read More
John G. Singer 10/30/24 John G. Singer 10/30/24 Escaping McKinseyLand is Hard, Even for McKinsey Read More
John G. Singer 10/10/24 John G. Singer 10/10/24 Missing From Starboard’s “Extensive Slide Deck” to Turn Around Pfizer Read More
John G. Singer 9/25/24 John G. Singer 9/25/24 A Note on the “Perverse Rebate System” in Action this Week Read More
John G. Singer 9/3/24 John G. Singer 9/3/24 When Big PBM Business Models Are “Dead Men Walking” Read More
